Figure (Humalogmix75 Ifu Qr)
Humalog Injection, Suspension
Product Images NDC 0002-7511
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Humalog (NDC 0002-7511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Humalogmix75 Kp Ifu 1 V2)
Humalog Mix75/25 KwikPen containing insulin lispro protamine and insulin lispro injectable suspension, 100 units/mL. The product is a subcutaneous injection suspension presented in a blue pen device. Label indicates single patient use. Manufactured by Eli Lilly and Company.*
Figure (Humalogmix75 Kp Ifu 10 V2)
An instructional illustration showing hands holding a syringe, with one hand gripping the syringe body and the other hand adjusting the plunger. This likely depicts a step in preparing Humalog Mix75/25 KwikPen insulin injection for subcutaneous administration.*
Figure (Humalogmix75 Kp Ifu 11 V2)
An instructional illustration showing a hand holding a Humalog Mix75/25 KwikPen insulin injection device with an arrow indicating the needle insertion site on the skin. A magnified inset highlights the needle properly positioned for subcutaneous injection.*
Figure (Humalogmix75 Kp Ifu 12 V2)
Illustration showing the dose selector window of the Humalog Mix75/25 KwikPen, an insulin lispro injection suspension for subcutaneous use. The image displays the dose dial indicator reading zero units, used for adjusting the insulin dose before injection.*
Figure (Humalogmix75 Kp Ifu 13 V2)
An instructional illustration showing the dose window of an insulin injection pen with a red arrow pointing upwards, indicating adjustment or selection of the dose. The pen is blue with visible dose numbers from 6 to 10.*
Figure (Humalogmix75 Kp Ifu 14 V2)
An illustration showing a close-up of a Humalog Mix75/25 KwikPen with a focus on the dosage window. The window displays numeric markings for dose measurement, with an arrow pointing at the number 12 on the dial, highlighting the dose selection mechanism.*
Figure (Humalogmix75 Kp Ifu 15 V2)
An instructional diagram showing a close-up view of a Humalog Mix75/25 KwikPen dose selector window. The window displays numbers for dose measurement with a red arrow pointing specifically at the number 26, indicating dose selection on the pen's dial.*
Figure (Humalogmix75 Kp Ifu 16 V1)
An anatomical illustration showing recommended injection sites on a human body for subcutaneous administration. Shaded areas include the abdomen, upper outer thighs, and the outer upper arms on both the front and back views of the body.*
Figure (Humalogmix75 Kp Ifu 17 V1)
An instructional illustration of a stopwatch showing 5 seconds, typically indicating a time duration for a specific step in medication administration or handling instructions.*
Figure (Humalogmix75 Kp Ifu 18 V2)
An instructional illustration showing a hand holding a Humalog Mix75/25 KwikPen insulin injection device aiming it at the abdomen for subcutaneous injection. The image demonstrates correct injection technique for insulin lispro injection suspension.*
Figure (Humalogmix75 Kp Ifu 20 V2)
An instructional line drawing showing how to remove the protective cap from a Humalog Mix75/25 KwikPen injection pen before use. The image depicts a hand gripping the pen and an arrow indicating the direction to pull off the cap.*
Figure (Humalogmix75 Kp Ifu 21 V2)
An instructional illustration showing the proper technique to mix a Humalog Mix75/25 KwikPen insulin pen injection by rolling and turning it gently between hands to suspend the insulin lispro injection evenly before use.*
Figure (Humalogmix75 Kp Ifu 22 V2)
An instructional diagram showing the removal of the cap from a Humalog Mix75/25 KwikPen insulin pen before use. The cap is shown being pulled straight off from the pen, which is displayed with its dosage window and label details visible.*
Figure (Humalogmix75 Kp Ifu 2a V2)
An illustrated diagram titled 'KwikPen Parts' showing labeled components of the Humalog Mix75/25 KwikPen insulin injection pen. Visible parts include the Pen Cap with Cap Clip, Cartridge Holder housing the insulin cartridge, Rubber Seal, Plunger, Label with product information, Pen Body, Dose Indicator, Dose Window, and Dose Knob.*
Figure (Humalogmix75 Kp Ifu 2b V2)
An instructional diagram showing the parts of a pen needle for injection use. It labels the outer needle shield, inner needle shield, needle, and paper tab, clarifying that needles are not included.*
Figure (Humalogmix75 Kp Ifu 3 V2)
An instructional diagram showing a Humalog Mix75/25 KwikPen insulin injection device with an arrow pointing left, indicating the action to remove or slide the pen cap.*
Figure (Humalogmix75 Kp Ifu 4 V2)
An instructional illustration showing two hands holding a vial of insulin suspension. One hand covers the vial while the other hand moves it back and forth, indicated by a red double-headed arrow, demonstrating the proper technique to mix the insulin suspension before use.*
Figure (Humalogmix75 Kp Ifu 5 V2)
An instructional diagram showing a hand holding a Humalog Mix75/25 KwikPen insulin injection device and demonstrating the proper motion or angle for rotating or adjusting the pen. The illustration includes arrows indicating the movement of the pen from one position to another.*
Figure (Humalogmix75 Kp Ifu 6 V1)
An instructional diagram showing a hand removing the cap from a vial or container by twisting it counterclockwise. A red arrow indicates the direction to turn the cap for removal.*
Figure (Humalogmix75 Kp Ifu 7 V1)
An instructional illustration showing a pen-style injection device with a cap being twisted or removed in a clockwise direction. The red arrow indicates the twisting motion on the threaded connection between the pen's cap and body.*
Figure (Humalogmix75 Kp Ifu 8 V1)
An instructional illustration showing three labeled images from left to right. The first shows an outer needle shield with an arrow pointing left and text instructing to "Keep Outer Needle Shield." The second shows an inner needle shield labeled "Throw Away Inner Needle Shield." The third image shows an insulin pen needle without any shields. This diagram is part of usage instructions for the Humalog Mix75/25 KwikPen injection.*
Figure (Humalogmix75 Kp Ifu 9 V2)
An instructional illustration showing a close-up view of a dose selector window on a Humalog Mix75/25 KwikPen insulin injection device. The window displays dose markings from 1 to 4 units, with a red arrow pointing upward, indicating dose adjustment or delivery direction.*
Package Carton – Humalog Mix75/25 Kwikpen 5ct (Humalogmix75 Kpen Carton 011 04)
Humalog Mix 75/25 KwikPen insulin lispro suspension injection, 100 units/mL, in 5 prefilled 3 mL pens. Label shows the product name, concentration U-100, usage instructions, and states it is for single patient use only. Manufactured by Eli Lilly and Company, this is a subcutaneous injectable insulin lispro protamine and insulin lispro mixture supplied in a prefilled insulin delivery device. The label includes storage instructions, warnings, and customer contact information.*
Primary Structure (Humalogmix75 Uspi Chem V1)
Chemical structure diagram showing the amino acid sequences of the A-chain and B-chain of insulin lispro, the active ingredient in Humalog Mix75/25 KwikPen 100 units/mL injection suspension by Eli Lilly and Company.*
Figure 1 (Humalogmix75 Uspi F1 V1)
A line graph showing glucose infusion rate (mg/min/kg) over time (hours) for different insulin formulations: Humalog, Humalog Mix50/50, Humalog Mix75/25, and ILPS. The graph compares their glucose infusion rates from 0 to 24 hours, illustrating differences in pharmacodynamic profiles.*
Figure 2 (Humalogmix75 Uspi F2 V1)
A line graph comparing glucose infusion rates over 12 hours between Humalog Mix75/25 and Humulin 70/30, both at a dose of 0.3 U/kg. The y-axis shows glucose infusion rate in mg/min/kg, and the x-axis shows time in hours. Humalog Mix75/25 demonstrates a higher and earlier peak glucose infusion rate than Humulin 70/30.*
Package Carton – Humalog Mix75/25 10 mL Vial 1ct (Humalogmix75 Vial Carton 014 01)
Packaging label for Humalog Mix75/25 KwikPen, an insulin lispro injection suspension. The label indicates a 10 mL vial with U-100 (100 units/mL) strength. The label includes warnings, storage instructions, barcodes, and labeling from Eli Lilly and Company. It specifies subcutaneous use and contains proprietary and generic names prominently.*
Figure (Humalogmix75 Vial Ifu 1 V1)
Humalog Mix75/25 KwikPen label on a clear vial with black protective cap, showing brand name, insulin lispro mixture designation (75/25), designation as injection suspension, Rx only, U-100 concentration, and manufacturer Eli Lilly and Company. The vial includes labeling for protective cap and rubber stopper under the cap.*
Figure (Humalogmix75 Vial Ifu 10 V1)
An instructional illustration showing the technique for withdrawing medication from a vial using a syringe. The image depicts a hand holding a vial upside down with a syringe needle inserted into it, alongside a close-up of the syringe barrel marked with volume increments from 10 to 40 units.*
Figure (Humalogmix75 Vial Ifu 11 V1)
An instructional line drawing showing two hands preparing an injection. One hand holds a vial upside down while the other hand holds a syringe, drawing liquid from the vial. The image demonstrates the step of filling a syringe from a vial for subcutaneous injection, relevant to insulin therapy such as Humalog Mix75/25 KwikPen.*
Figure (Humalogmix75 Vial Ifu 12 V1)
An instructional diagram showing hands drawing dosage from a vial into a syringe. The syringe shown has markings up to 40 units, and an arrow indicates upward movement, likely demonstrating how to withdraw the medication. This illustration relates to the injection preparation process for Humalog Mix75/25 KwikPen insulin suspension.*
Figure (Humalogmix75 Vial Ifu 13 V1)
Illustration showing a hand holding an insulin vial and another hand inserting a syringe needle upward into a subcutaneous site on the forearm, indicating the proper injection technique for Humalog Mix75/25 KwikPen insulin lispro injection suspension.*
Figure (Humalogmix75 Vial Ifu 14 V1)
An anatomical diagram showing front and back views of a human figure with shaded areas indicating recommended injection sites. Shaded areas include the abdomen (around the navel and lower abdomen), the front and outer thighs, and the upper buttocks/lower back regions.*
Figure (Humalogmix75 Vial Ifu 15 V1)
An instructional illustration showing a person administering a subcutaneous injection into the abdomen. A hand is holding a syringe positioned near the skin around the stomach area, indicating the injection site for Humalog Mix75/25 KwikPen insulin lispro suspension.*
Figure (Humalogmix75 Vial Ifu 16 V1)
An instructional illustration showing the proper technique for administering a subcutaneous injection using a pen device. The image depicts one hand pinching the skin of the abdomen while the other hand inserts a needle at an angle into the pinched skin area.*
Figure (Humalogmix75 Vial Ifu 17 V1)
An instructional illustration showing a hand holding a syringe or pen injector, positioned for subcutaneous injection into the abdominal area just below the skin's surface, indicating the correct injection technique for administration.*
Figure (Humalogmix75 Vial Ifu 2 V1)
An illustration showing the parts of an insulin syringe including the needle shield, needle, plunger tip, syringe body, and plunger. The syringe body is marked with unit measurements up to 100 units, with a zoomed inset highlighting an example dose of 20 units at the plunger tip.*
Figure (Humalogmix75 Vial Ifu 3 V1)
An instructional diagram showing two hands holding a vial or pen, with arrows indicating a back-and-forth rolling motion to mix the contents before use.*
Figure (Humalogmix75 Vial Ifu 4 V1)
An instructional illustration showing a hand holding a small vial between the thumb and fingers. Arrows indicate a rocking motion to gently mix the contents, likely demonstrating how to prepare an insulin suspension injection before use.*
Figure (Humalogmix75 Vial Ifu 5 V1)
An instructional line drawing showing a hand holding a vial, with an arrow indicating an upward motion, presumably illustrating how to prepare or handle the vial for injection.*
Figure (Humalogmix75 Vial Ifu 6 V1)
Illustration showing a person's hands holding a vial with one hand and removing the cap with the other hand, demonstrating how to open a vial for injection preparation.*
Figure (Humalogmix75 Vial Ifu 7 V1)
An instructional illustration showing a person holding a syringe filled with liquid, with one hand holding the syringe barrel and the other hand pressing down on the plunger. A close-up inset shows the syringe barrel with volume markings from 0 to 40 units.*
Figure (Humalogmix75 Vial Ifu 8 V1)
An instructional illustration showing hands drawing insulin from a vial into a syringe, demonstrating the preparation of an injectable insulin dose. The syringe is held in one hand with the needle inserted into the vial, indicated by an arrow showing the motion.*
Figure (Humalogmix75 Vial Ifu 9 V1)
An instructional diagram showing a person preparing an insulin injection by attaching a syringe needle to a vial. The image highlights the proper technique for handling the vial and syringe where the user holds the vial with one hand and inserts the needle with the other, guided by an arrow emphasizing the action.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
